Modulation of urokinase-type plasminogen activator by transforming growth factor β1 in acetaldehyde-activated hepatic stellate cells

Pharmacology

Volumn 73, Issue 1, 2005, Pages 23-30

  Pérez Liz, Georgina ^a   Flores Hernández, Jorge ^a   Arias Montaño, José Antonio ^b   Reyes Esparza, Jorge Alberto ^c   Rodríguez Fragoso, Lourdes ^c  

^a UNIVERSIDAD PANAMERICANA   (Mexico)

^b DEPARTAMENTO DE FÍSICA   (Mexico)

^c UNIVERSIDAD AUTÓNOMA DEL ESTADO DE MORELOS   (Mexico)

Author keywords

Collagen; Fibrosis; Hepatic stellate cells; Transforming growth factor 1; Urokinase type plasminogen activator

Indexed keywords

ACETALDEHYDE; COLLAGEN; TRANSFORMING GROWTH FACTOR BETA1; UROKINASE RECEPTOR;

ANIMAL CELL; ARTICLE; CELL ACTIVATION; CELL LYSATE; COLLAGEN SYNTHESIS; CONTROLLED STUDY; ENZYME ACTIVITY; GENE EXPRESSION; LIVER CELL; MOLECULAR MECHANICS; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN SECRETION; PROTEIN SYNTHESIS; RAT; STELLATE CELL; WESTERN BLOTTING;

ACETALDEHYDE; ANIMALS; BLOTTING, WESTERN; CARBON TETRACHLORIDE POISONING; COLLAGEN; CULTURE MEDIA, CONDITIONED; HEPATOCYTES; LIVER; RATS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1; URINARY PLASMINOGEN ACTIVATOR;

EID: 10844237902     PISSN: 00317012     EISSN: None     Source Type: Journal    
DOI: 10.1159/000081071     Document Type: Article

References (39)

1. Neubauer K, Saile B, Ramadori G: Liver fibrosis and altered matrix synthesis. Can J Gastroenterol 2001;15:187-193.
2. Kovalszky I, Nagy P, Szende BB, Lapis K, Szalay F, Jeney A, Schaff Z: Experimental and human liver fibrogenesis. Scand J Gastroenterol Suppl 1998;228:51-55.
3. Rockey DC: The cell and molecular biology of hepatic fibrogenesis. Clinical and therapeutic implications. Clin Liver Dis 2000;4:319-355.
4. Friedman SL: Seminars in medicine of the Beth Israel Hospital, Boston. The cellular basis of hepatic fibrosis. Mechanisms and treatment strategies. N Engl J Med 1993;328:1828-1835.
5. Pinzani M, Gentilini P: Biology of hepatic stellate cells and their possible relevance in the pathogenesis of portal hypertension in cirrhosis. Semin Liver Dis 1999;19:397-410.
6. Suzuki C, Kayano K, Uchida K, Sakaida I, Okita K: Characteristics of the cell proliferation profile of activated rat hepatic stellate cells in vitro in contrast to their fibrogenesis activity. J Gastroenterol 2001;36:322-329.
7. Gressner AM: Cytokines and cellular crosstalk involved in the activation of fast-storing cells. J Hepatol 1995;22:28-36.
8. Tsukamoto H: Cytokine regulation of hepatic stellate cells in liver fibrosis. Alcohol Clin Exp Res 1999;23:911-916.
9. Dooley S, Delvoux B, Streckert M, Bonzel L, Stopa M, Ten Dijke P, Gressner AM: Transforming growth factor-β signal transduction in hepatic stellate cells via Sma 2/3 phosphorylation, a pathway that is abrogated during in vitro progression to myofibroblast. TGF-β signal transduction during transdifferentiation of hepatic stellate cells. FEBS Lett 2001;502:4-10.
10. Border WA, Noble NA: Transforming growth factor-β in tissue fibrosis. N Engl J Med 1994; 331:1286-1294.
11. Santos RM, Norton P, Degli E, Zern MA: TGF-β isoforms in alcoholic liver disease. J Gastroenterol 1998;33:383-389.
12. Baricos WH, Cortez SL, Deboisblane M, Xin S: Transforming growth factor-β is a potent inhibitor of extracellular matrix degradation by cultured human mesangial cells. J Am Soc Nephrol 1999;10:790-795.
13. 1 in liver fibrosis: An inducible transgenic mouse model to study liver fibrogenesis. Am J Physiol 1999;276:G1059-G1068.
14. Bedosa P, Paradis V: Transforming growth factor-β: A key role in liver fibrogenesis. J Hepatol 1995;22:37-42.
15. De Bleser PJ, Niki T, Rogiers V, Geerts A: Transforming growth factor-β gene expression in normal and fibrotic rat liver. J Hepatol 1997;26:886-893.
16. 1 in plasma and liver of children with liver disease. Pediatr Res 1998;44:402-409.
17. Branton MH, Kopp JB: TGF-β and fibrosis. Microbes Infect 1999;1:1349-1365.
18. 1 in initiating hepatic stellate cell activation in vivo. J Hepatol 1999;30:77-87.
19. Fitch P, Bennett B, Booth NA, Croll A, Ewen SWB: Distribution of plasminogen activator inhibitor in normal liver, cirrhotic liver and liver with metastases. J Clin Pathol 1994;47:218-221.
20. Seki T, Imai H, Uno S, Arriaga T, Gelehrter TD: Production of tissue-type plasminogen activator and type 1 plasminogen activator inhibitor in mildly cirrhotic rat liver. Thromb Haemost 1996;75:801-807.
21. Zhang LP, Takahara T, Yata Y, Fururi K, Jin B, Kawada N, Watanabe A: Increased expression of plasminogen activator and plasminogen activator inhibitor during liver fibrogenesis of rats: Role of stellate cells. J Hepatol 1999;31:703-711.
22. Murphy G, Atkinson S, Ward R, Gavrilovic J, Reynolds JJ: The role of plasminogen activators in the regulation of connective tissue metalloproteinases. Ann NY Acad Sci 1992;667:1-12.
23. Knittel T, Fellmar P, Ramadori G: Gene expression and regulation of plasminogen activator inhibitor type I in hepatic stellate cells of rat liver. Gastroenterology 1996;111:745-754.
24. Leyland H, Gentry J, Arthur MJ, Benyon C: The plasminogen activator system in hepatic stellate cells. Hepatology 1996;24:1172-1178.
25. Rodríguez-Fragoso L, Alvarez R, Reyes-Esparza JA, Garcés ME: Acetaldehyde increases the activity and gene expression of urokinase type plasminogen activator in a hepatic stellate cell line. Toxicology 2000;137:1-11.
26. Friedman SL: Acetaldehyde and alcoholic fibrogenesis: Fuel to the fire, but not the spark. Hepatology 1990;12:609-612.
27. Barry RE, McGivan JD: Acetaldehyde alone may initiate hepatocellular damage in acute alcoholic liver disease. Gut 1985;26:1065-1072.
28. Brenner DA, Chojkier M: Acetaldehyde increases collagen gene transcription in cultured human fibroblast. J Biol Chem 1987;262:17690-17695.
29. Hoestage A, Bedosa P, Poynard T: Acetaldehyde-modified epitopes in liver biopsy specimens of alcoholic and non-alcoholic patients: Localization and association with progression of liver fibrosis. Hepatology 1995;19:367-374.
30. Gressner AM: Transdifferentiation of hepatic stellate cell (Ito cells) to myofibroblasts: A key event in hepatic fibrogenesis. Kidney Int Suppl 1996;54:S39-S45.
31. Woessner JF: The determination of hydroxyproline in tissue and protein samples containing small proportions of this imino acid. Arch Biochem Biophys 1961;93:440-447.
32. Miskin R, Soreq H: Sensitive autoradiographic quantitation of electrophoretically separated proteases. Anal Biochem 1981;118:252-258.
33. Laemmli UK: Cleavage of structural protein during the assembly of the head of bacteriophage. Nature 1970;227:680-685.
34. Chomczynski P, Sacchi N: Single step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987;162:157-163.
35. Mochisuki H, Nishi T, Brunner JM, Lee SY, Levin VA, Saya SH: Alternative splicing of neurofibromatosis type 1 gene transcript in malignant brain tumor: PCR analysis of frozen-section mRNA. Mol Carcinog 1992;6:83-88.
36. Rosenbaum J, Blazejewski S: Regulation of Ito cell proliferation by soluble factors. J Hepatol 1995;22:65-70.
37. Sieuwerts AM, Klijn JG, Henzen-Logmans SC, Foekens JA: Cytokine-regulated urokinase-type plasminogen activator (uPA) production by human breast fibroblast in vitro. Breast Cancer Res Treat 1999;55:9-20.
38. Siren V, Myohanen H, Vaheri A, Immonen I: Transforming growth factor-β induces urokinase receptor expression in cultured retinal epithelial cells. Ophthalmic Res 1999;31:184-191.
39. Niemela O: Acetaldehyde protein adducts in the liver as a result of ethanol-induced oxidative stress. Front Biosci 1999;4:D506-D513.